Wednesday, April 22, 2020

Gilead's Remdesivir effective in Rockville study of monkeys with coronavirus covid-19

A study at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases {(NIAID) in Rockville has shown that pharmaceutical firm Gilead's experimental Remdesivir anti-viral treatment slowed the progression of the covid-19 coronavirus in monkeys infected with the virus. It also reduced lung damage.

Early administration of the drug made it more effective, according to a report on the study by The drug did not reduce the monkey's shedding of the virus while infected, however, which means they would remain contagious even while on Remdesivir, if this study's finding holds in further clinical testing.

The NIAID is at 5601 Fishers Lane in the Twinbrook area of Rockville.


  1. Its probably going to have to be herd immunity that ends this.Protection of the vulnerable and just hope and pray you don't get it really bad.